Join us now
The Calcitonin Gene-Related Peptide (CGRP) Forum has been established by an international group of clinicians and researchers. It provides all healthcare professionals with open and free access to independent news, information, comment and resources about the exciting potential of CGRP as a novel therapeutic target for the prevention of migraine in millions of people worldwide.
CGRP therapies in acute migraine
As clinicians await the US approval of the first CGRP small molecule receptor antagonist, ubrogepant, for the acute treatment of migraine, Peter Goadsby looks at the potential impact of targeting the CGRP pathway for both prevention and treatment of migraine.Become a member-->
Why is CGRP an important therapeutic target?
Multiple lines of evidence support a role for CGRP in migraine pathophysiology.
Its blockade is now a potentially important therapeutic target for migraine prevention.Read more Become a member